Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.28 USD
+0.05 (4.07%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $1.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PACB 1.28 +0.05(4.07%)
Will PACB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PACB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PACB
Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today
PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq
PACB: What are Zacks experts saying now?
Zacks Private Portfolio Services
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates
Other News for PACB
Sideways movement on September 17 results in no shift to PACB’s technical outlook
Technical picture remains unchanged for PACB after it rises 2.5% on September 16
Technical picture remains unchanged for PACB after it rises 2.56% on September 15
PACB falls 7.14% on September 12, leaving the technical picture intact
The technical outlook for PACB is unchanged after it rises 3.28% on September 11